According to traditional total prescription (TRx) metrics, there were 2.3 million prescriptions for Diovan HCT in the second quarter of 2004. However, Verispan's Total Patient Tracker, which measures market sizes by viewing unique patients, shows the actual number of patients who filled prescriptions for the hypertension drug during the same time period was 1.1 million--less than half the number of prescription transactions.
